This secondary analysis of the DE-ESCALATE HPV trial reports surveillance with coupled plasma and serum HPV testing is 65% sensitive and 87% specific at detecting early recurrences of low-risk HPV-associated oropharyngeal cancers with a mean lead time prior to radiographic recurrence of—get this—122 days. | Califano, JAMA Otolaryngol Head Neck Surg 2023
